Position in APGE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,313,725
New position
Shares Held
32,500
first reported quarter
Ownership
0.043%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#126
of 285 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alpine Global Management, LLC holds $66,598,591 across 8 Biotechnology names. APGE ranks #2 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
|
1,375,000 | $52,978,750 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
This page
|
32,500 | $4,313,725 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
6,033 | $3,239,419 | |
| 4 | TECH |
BIO-TECHNE Corp
|
40,000 | $2,826,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
33,339 | $2,717,461 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,467 | $441,611 | |
| 7 | ACHV |
Achieve Life Sciences, Inc.
|
12,500 | $81,625 | |
| 8 | 1,643 | $0 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,313,725 | 32,500 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||